Therapeutic use of anti-CS1 antibodies

Details for Australian Patent Application No. 2004238363 (hide)

International Classifications

Event Publications

24 November 2005 PCT application entered the National Phase

PCT publication WO2004/100898 Priority application(s): WO2004/100898

22 October 2009 Assignment before Grant

PDL BioPharma, Inc. The application has been assigned to Facet Biotech Corporation

29 April 2010 Amendment Made

The nature of the amendment is: Add co-inventor Liu, Gao; Powers, David B.

27 May 2010 Application Accepted

Published as AU-B-2004238363

23 September 2010 Standard Patent Sealed

27 January 2011 Alteration of Name

The name of the patentee has been altered to Abbott Biotherapeutics Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.